KROSNasdaq United States
Market cap
$221.073 M
$11.15 +4.70%
Close of 7 Aug 2026
Revenue
$243.9M
#2230 by revenue
Earnings
$87.0M
#1366 by earnings
Shares outstanding
19,827,188
Latest filing cover page
P/E ratio
2.5
Cap ÷ net income
Where these numbers come from
Share counts and financials for Keros Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.